Privia Health Group, Inc. (NASDAQ:PRVA) Shares Bought by Northern Trust Corp

Northern Trust Corp raised its position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 14.2% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 1,392,641 shares of the company's stock after purchasing an additional 173,563 shares during the period. Northern Trust Corp owned about 1.16% of Privia Health Group worth $27,226,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in PRVA. Rhumbline Advisers raised its holdings in shares of Privia Health Group by 1.3% in the fourth quarter. Rhumbline Advisers now owns 287,200 shares of the company's stock worth $5,615,000 after acquiring an additional 3,658 shares during the last quarter. Barclays PLC lifted its stake in shares of Privia Health Group by 240.3% in the 3rd quarter. Barclays PLC now owns 224,018 shares of the company's stock valued at $4,079,000 after purchasing an additional 158,188 shares in the last quarter. JPMorgan Chase & Co. lifted its position in Privia Health Group by 8.4% during the third quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company's stock valued at $3,430,000 after buying an additional 14,641 shares in the last quarter. Choreo LLC boosted its position in Privia Health Group by 8.7% during the 4th quarter. Choreo LLC now owns 21,841 shares of the company's stock worth $425,000 after purchasing an additional 1,752 shares during the period. Finally, PNC Financial Services Group Inc. boosted its position in shares of Privia Health Group by 8.0% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company's stock worth $140,000 after buying an additional 533 shares during the period. Hedge funds and other institutional investors own 94.48% of the company's stock.

Privia Health Group Price Performance

NASDAQ:PRVA remained flat at $24.30 during trading hours on Wednesday. The company's stock had a trading volume of 823,589 shares, compared to its average volume of 767,269. The firm has a market cap of $2.95 billion, a PE ratio of 243.02, a P/E/G ratio of 3.47 and a beta of 0.87. The company's 50 day moving average is $23.35 and its 200 day moving average is $22.40. Privia Health Group, Inc. has a 52 week low of $15.92 and a 52 week high of $26.09.

Analysts Set New Price Targets

Several equities analysts recently commented on PRVA shares. Piper Sandler boosted their price target on Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a research report on Friday, February 28th. JMP Securities reissued a "market outperform" rating and set a $29.00 target price on shares of Privia Health Group in a research report on Monday, April 28th. Truist Financial raised their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the company a "buy" rating in a report on Thursday, April 10th. Needham & Company LLC reissued a "buy" rating and issued a $30.00 price objective on shares of Privia Health Group in a research report on Thursday, April 10th. Finally, Barclays lifted their target price on Privia Health Group from $21.00 to $23.00 and gave the stock an "equal weight" rating in a research report on Thursday, April 10th. One equities research analyst has rated the stock with a hold rating, eleven have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $27.38.

Insider Activity at Privia Health Group

In related news, CFO David Mountcastle sold 3,445 shares of the business's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total transaction of $80,371.85. Following the completion of the transaction, the chief financial officer now owns 176,231 shares in the company, valued at $4,111,469.23. The trade was a 1.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Parth Mehrotra sold 15,100 shares of the company's stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total transaction of $352,283.00. Following the transaction, the chief executive officer now owns 454,281 shares of the company's stock, valued at $10,598,375.73. This represents a 3.22% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 34,484 shares of company stock valued at $799,163. Corporate insiders own 10.70% of the company's stock.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.